mavacamten
bms
['cardiomyopathy', 'cardio', 'hypertrophic cardiomyopathy', 'mavacamten']
a -led trial finds a medication, mavacamten, reduced the need for surgery in 88% of patients with severe hypertrophic cardiomyopathy. #aha22 
Your source for @ClevelandClinic news | Inspiring patients, medical innovation,  healthcare leaders, breakthrough research | Media requests: newsroom@ccf.org